Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Figs Inc (FIGS) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Figs Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Figs Inc trades at $18.54 (market cap $2.99B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Figs Inc is the larger of the two by market cap, and Figs Inc is trading nearer its 52-week high, Vir Biotechnology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Figs Inc for 31 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

FIGSVIR
Market Cap
$2.99B$1.80B
Volume
6,721,4811,782,836
Sector
Consumer CyclicalHealth
52-Week High
$18.63$11.78
52-Week Low
$7.38$5.12
Typical Hold Time
31 Days0 Days
Enterprise Value
$2.75B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Figs Inc

FIGS stock trades at $18.63, up 4.9% today, showing strong momentum with three consecutive quarterly earnings beats. The company demonstrates robust fundamentals with 68.9% gross margins and accelerating revenue growth from $556M in 2024 to projected $710M in 2026. Technical indicators show bullish momentum with the stock trading near resistance at $19, though RSI levels suggest potential overbought conditions. Recent news highlights international expansion success with 67% Q2 international sales growth and raised 2026 guidance.

The outlook remains positive with analyst consensus pointing to 26% upside potential to $18 target, though the premium valuation (P/E 54.6) requires continued execution. Key risks include rich valuation multiples and competitive pressures in healthcare apparel. The combination of strong earnings momentum, international growth, and bullish technicals supports further upside if the company maintains its growth trajectory.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FIGS
4% Buy96% Sell
Avg holding period · 31 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Figs Inc

FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.

Read more on FIGS →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →